Grant-Back License. Subject to the terms and conditions of this Agreement, ArriVent hereby grants to Allist a non-exclusive license (with the right to grant sublicenses through multiple tiers) to use the ArriVent Results and ArriVent Improvements to Exploit the Licensed Compounds and Products in the Field and in the Retained Territory.
Appears in 3 contracts
Sources: Global Technology Transfer and License Agreement (ArriVent Biopharma, Inc.), Global Technology Transfer and License Agreement (ArriVent Biopharma, Inc.), Global Technology Transfer and License Agreement (ArriVent Biopharma, Inc.)